Distribution of lenacapavir, a twice-yearly HIV prevention drug, has begun.
Lenacapavir is a drug administered by injection every six months, and its distribution is now starting. The rollout is global but targeted to areas with the greatest need. The effort is in its early stages, and there are concerns about equitable access.
Why it matters
This provides a new, long-lasting option for preventing HIV infection, which remains a persistent global health challenge.
CHECKED · 1 SOURCE · UNCORROBORATED
← All news